HIV infection is associated with reduced pulmonary diffusing capacity

Kristina Crothers, Kathleen McGinnis, Eric Kleerup, Cherry Wongtrakool, Guy S. Hoo, Joon Kim, Amir Sharafkhaneh, Laurence Huang, Zhaoyu Luo, Bruce Thompson, Philip Diaz, Gregory D. Kirk, William Rom, Roger Detels, Lawrence Kingsley, Alison Morris

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: Prior studies comparing abnormalities in pulmonary function between HIV-infected and HIV-uninfected persons in the current era are limited. OBJECTIVES: To determine the pattern and severity of impairment in pulmonary function in HIV-infected compared with HIV-uninfected individuals. METHODS: Cross-sectional analysis of 300 HIV-infected men and 289 HIV-uninfected men enrolled from 2009 to 2011 in 2 clinical centers of the Lung HIV Study. Participants completed pre- and postbronchodilator spirometry, diffusing capacity of the lung for carbon monoxide (DLCO) measurement, and standardized questionnaires. RESULTS: Most participants had normal airflow; 18% of HIV-infected and 16% of HIV-uninfected men had airflow obstruction. The mean percent predicted DLCO was 69% in HIV-infected vs. 76% in HIV-uninfected men (P < 0.001). A moderately to severely reduced DLCO of ≤60% was observed in 30% of HIV-infected compared with 18% of HIV-uninfected men (P < 0.001), despite the fact that 89% of those with HIV were on antiretroviral therapy. A reduced DLCO was significantly associated with HIV and CD4 cell count in linear regression adjusting for smoking and other confounders. The DLCO was lowest in HIV-infected men with CD4 cell counts <200 cells per microliter compared with those with CD4 cell counts ≥200 cells per microliter and to HIV-uninfected men. Respiratory symptoms of cough, phlegm and dyspnea were more prevalent in HIV-infected patients particularly those with abnormal pulmonary function compared with HIV-uninfected patients. CONCLUSIONS: HIV infection is an independent risk factor for reduced DLCO, particularly in individuals with a CD4 cell count below 200 cells per microliter. Abnormalities in pulmonary function among HIV-infected patients manifest clinically with increased respiratory symptoms. Mechanisms accounting for the reduced DLCO require further evaluation.

Original languageEnglish (US)
Pages (from-to)271-278
Number of pages8
JournalJournal of acquired immune deficiency syndromes
Volume64
Issue number3
DOIs
StatePublished - Nov 1 2013

Keywords

  • COPD
  • DLCO
  • FEV1
  • HIV/AIDS
  • gas exchange
  • pulmonary function

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'HIV infection is associated with reduced pulmonary diffusing capacity'. Together they form a unique fingerprint.

  • Cite this

    Crothers, K., McGinnis, K., Kleerup, E., Wongtrakool, C., Hoo, G. S., Kim, J., Sharafkhaneh, A., Huang, L., Luo, Z., Thompson, B., Diaz, P., Kirk, G. D., Rom, W., Detels, R., Kingsley, L., & Morris, A. (2013). HIV infection is associated with reduced pulmonary diffusing capacity. Journal of acquired immune deficiency syndromes, 64(3), 271-278. https://doi.org/10.1097/QAI.0b013e3182a9215a